These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 23474494

  • 1. The relevance of the TGF-β Paradox to EMT-MET programs.
    Morrison CD, Parvani JG, Schiemann WP.
    Cancer Lett; 2013 Nov 28; 341(1):30-40. PubMed ID: 23474494
    [Abstract] [Full Text] [Related]

  • 2. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression.
    Wendt MK, Tian M, Schiemann WP.
    Cell Tissue Res; 2012 Jan 28; 347(1):85-101. PubMed ID: 21691718
    [Abstract] [Full Text] [Related]

  • 3. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
    Saitoh M.
    Cancer Sci; 2015 May 28; 106(5):481-8. PubMed ID: 25664423
    [Abstract] [Full Text] [Related]

  • 4. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y, Lamouille S, Derynck R.
    Curr Opin Oncol; 2013 Jan 28; 25(1):76-84. PubMed ID: 23197193
    [Abstract] [Full Text] [Related]

  • 5. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA, Palmer TD, Ashby WJ, Nashabi A, Chytil A, Aakre M, Pickup MW, Gorska AE, Zijlstra A, Moses HL.
    Breast Cancer Res; 2012 Jul 02; 14(4):R98. PubMed ID: 22748014
    [Abstract] [Full Text] [Related]

  • 6. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA, Parvani JG, Schiemann WP.
    J Mammary Gland Biol Neoplasia; 2010 Jun 02; 15(2):169-90. PubMed ID: 20467795
    [Abstract] [Full Text] [Related]

  • 7. Alternative splicing in EMT and TGF-β signaling during cancer progression.
    Zhang YE, Stuelten CH.
    Semin Cancer Biol; 2024 Jun 02; 101():1-11. PubMed ID: 38614376
    [Abstract] [Full Text] [Related]

  • 8. TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition.
    Shirakihara T, Horiguchi K, Miyazawa K, Ehata S, Shibata T, Morita I, Miyazono K, Saitoh M.
    EMBO J; 2011 Feb 16; 30(4):783-95. PubMed ID: 21224849
    [Abstract] [Full Text] [Related]

  • 9. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
    Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, Ford HL.
    Oncogene; 2012 Dec 13; 31(50):5162-71. PubMed ID: 22286770
    [Abstract] [Full Text] [Related]

  • 10. Noncanonical TGF-β signaling during mammary tumorigenesis.
    Parvani JG, Taylor MA, Schiemann WP.
    J Mammary Gland Biol Neoplasia; 2011 Jun 13; 16(2):127-46. PubMed ID: 21448580
    [Abstract] [Full Text] [Related]

  • 11. TGF-beta-induced epithelial to mesenchymal transition.
    Xu J, Lamouille S, Derynck R.
    Cell Res; 2009 Feb 13; 19(2):156-72. PubMed ID: 19153598
    [Abstract] [Full Text] [Related]

  • 12. Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis.
    Ding X, Park SI, McCauley LK, Wang CY.
    J Biol Chem; 2013 Apr 12; 288(15):10241-53. PubMed ID: 23447531
    [Abstract] [Full Text] [Related]

  • 13. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.
    Allington TM, Schiemann WP.
    Cells Tissues Organs; 2011 Apr 12; 193(1-2):98-113. PubMed ID: 21051857
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.
    Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim YY, Lindeman GJ, Shannon MF, Drew PA, Khew-Goodall Y, Goodall GJ.
    Mol Biol Cell; 2011 May 15; 22(10):1686-98. PubMed ID: 21411626
    [Abstract] [Full Text] [Related]

  • 16. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
    Galliher AJ, Schiemann WP.
    Breast Cancer Res; 2006 May 15; 8(4):R42. PubMed ID: 16859511
    [Abstract] [Full Text] [Related]

  • 17. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.
    Oncogene; 2013 Dec 12; 32(50):5614-24. PubMed ID: 23955085
    [Abstract] [Full Text] [Related]

  • 18. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Jiang Y, Feng X, Zheng L, Li SL, Ge XY, Zhang JG.
    Oncotarget; 2015 Sep 22; 6(28):25506-19. PubMed ID: 26325518
    [Abstract] [Full Text] [Related]

  • 19. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT.
    Int J Oncol; 2014 May 22; 44(5):1643-51. PubMed ID: 24573038
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes.
    Fuxe J, Vincent T, Garcia de Herreros A.
    Cell Cycle; 2010 Jun 15; 9(12):2363-74. PubMed ID: 20519943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.